Know Cancer

or
forgot password

Breast Cancer Recurrence - the Accuracy of Dual-time PET/CT


N/A
18 Years
N/A
Open (Enrolling)
Female
Breast Cancer Recurrent

Thank you

Trial Information

Breast Cancer Recurrence - the Accuracy of Dual-time PET/CT


Inclusion Criteria:



- Clinical suspected recurrence of breast cancer

- Blood glucose level less than 8,0 mmol/L

Exclusion Criteria:

- Disqualified patients

- Other malignancies

- < 18 years

- < 50 kg

- > 90 kg

- Pregnant or lactating

- Patients with permanent address outside of the Region of Southern Denmark

- Estimated inability to collaborate

Type of Study:

Interventional

Study Design:

Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Single Blind (Investigator), Primary Purpose: Diagnostic

Outcome Measure:

Diagnostic value of dual-time point 18FDG PET/CT in recurrent breast cancer

Outcome Description:

The sensitivity and specificity of dual-time point 18FDG PET/CT will be compared to conventional imaging modalities usually used in the work up of patients with suspected recurrent breast cancer. In this case CT of thorax and upper abdomen and bone scintigraphy.

Outcome Time Frame:

2 years

Safety Issue:

No

Principal Investigator

Malene Hildebrandt, M.D.

Investigator Role:

Principal Investigator

Investigator Affiliation:

Dept. Nuclear Medicine, Odense University Hospital

Authority:

Denmark: The Danish National Committee on Biomedical Research Ethics

Study ID:

BREAC-AUT

NCT ID:

NCT01552655

Start Date:

December 2011

Completion Date:

December 2013

Related Keywords:

  • Breast Cancer Recurrent
  • Dual-time PET/CT
  • Breast cancer recurrence
  • Bone scintigraphy
  • CT thorax upper abdomen
  • Breast Neoplasms
  • Recurrence

Name

Location